Table 3.
Description of Outcome Variables and Relevant Covariate Informationa
| Parameter | No. of Participants | % of Participants |
|---|---|---|
| Reasons for NOT measuring heart rate (HR) and blood pressure (BP)b (n = 1544) | ||
| Equipment not available | 93 | 6.0 |
| Lack of clinic/department/institutional policy | 222 | 14.4 |
| Not certain of ability to perform measurements competently | 18 | 1.2 |
| Not certain of what to do with the information | 107 | 6.9 |
| Lack of time | 578 | 37.4 |
| Not important for my patient population | 550 | 35.6 |
| Other | 414 | 26.8 |
| Reasons for measuring HR and BPb (n = 268) | ||
| Certain of ability to perform these measurements competently | 78 | 29.1 |
| Clinic/department/institutional policy | 103 | 38.4 |
| Important for my patient population | 213 | 79.5 |
| Required for insurance reimbursement | 8 | 3.0 |
| Other | 43 | 16.0 |
| Tests/measures comfortable using to screen cardiovascular stabilityc | ||
| Activity or health history questionnaire (eg, PARQ, DASI) | 743 | 41.0 |
| Anthropometric measurements (body weight, BMI, waist circumference) | 1050 | 57.9 |
| Static (ie, rest and recovery) measures of HR and BP | 1688 | 93.2 |
| RPE | 1371 | 75.7 |
| Exercise testing (eg, CPX, 6MWT, Step Test, Graded Exercise Tolerance Test) | 678 | 37.4 |
| Dynamic/concurrent exercising measurements of HR and BP | 736 | 40.6 |
| Other | 17 | 0.9 |
| None | 22 | 1.2 |
| Measures currently used to screen for heart diseasec | ||
| Anthropometric measurements (body weight, BMI, waist circumference) | 646 | 35.7 |
| Concurrent exercising measurements of HR and BP | 210 | 11.6 |
| Exercise testing (eg, CPX, 6MWT, Step Test, Graded Exercise Tolerance Test) | 313 | 17.3 |
| Validated activity or health history questionnaire (eg, PARQ, DASI) | 301 | 16.6 |
| RPE | 776 | 42.8 |
| Resting HR and BP measurements | 1295 | 71.5 |
| Response and recovery HR and BP measurements | 632 | 34.9 |
| Other | 77 | 4.2 |
| None | 223 | 12.3 |
| Cardiopulmonary assessment equipmentc | ||
| Electronic BP monitor | 1003 | 55.4 |
| Pulse oximeter | 1375 | 75.9 |
| Telemetry device or 12-lead ECG | 40 | 2.2 |
| Sphygmomanometer (BP cuff) | 1704 | 94.0 |
| Stethoscope | 1687 | 93.1 |
| Doppler ultrasound device | 38 | 2.1 |
| Other | 12 | 0.7 |
| None | 20 | 1.1 |
| Exercise equipment (select all that apply) | ||
| 50-cm or 20-in step/platform or standard stairs | 1257 | 69.4 |
| A hallway or floor at least ∼ 30 m (100 ft) long | 1360 | 75.1 |
| NuStepd or reciprocal stepper | 883 | 48.7 |
| Stationary bike | 1698 | 93.7 |
| Treadmill | 1652 | 91.2 |
| Other | 59 | 3.3 |
| None | 17 | 0.9 |
| Where tests and measures used were learned | ||
| Undergraduate studies prior to physical therapist school | 409 | 22.6 |
| Physical therapist school | 1719 | 94.9 |
| Continuing education and in-service or employee training | 713 | 39.3 |
| Self-education (eg, reading manuscripts and texts) | 604 | 33.3 |
| Postprofessional residency or fellowship | 212 | 11.7 |
| Other | 77 | 4.2 |
For 1812 participants unless otherwise noted. BMI = body mass index; CPX = Cardiopulmonary Exercise Test; DASI = Duke Activity Status Index; ECG = electrocardiogram; PARQ = Physical Activity Readiness Questionnaire; RPE, rating of perceived exertion; 6MWT = 6-Minute Walk Test.
n is less than 1812 (participants only fell in 1 of these 2 categories).
n exceeds 1812 (participants could select multiple options).
NuStep LLC, Ann Arbor, MI, USA.